Peak Bio

Peak Bio is a clinical-stage biopharmaceutical company focused on developing treatments to address significant unmet needs in the fields of oncology and inflammation. Peak Bio's management team has 50 years of industry experience in the small molecule, antibody, and antibody-drug conjugate (ADC) sectors, successfully building companies that create first-class therapies.